Soleno Therapeutics (SLNO)
(Delayed Data from NSDQ)
$81.63 USD
-2.49 (-2.96%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $81.63 0.00 (0.00%) 7:44 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Soleno Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SLNO 81.63 -2.49(-2.96%)
Will SLNO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLNO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLNO
Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy?
Can Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect?
SLNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price Strength
Soleno Therapeutics (SLNO) is on the Move, Here's Why the Trend Could be Sustainable
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug
Other News for SLNO
Soleno Therapeutics's Earnings: A Preview
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
Janus Henderson Global Life Sciences Fund Q2 2025 Commentary
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 ...
Soleno Therapeutics Inc (SLNO) Announces Upcoming Financial Results and Operational Highlights ...